Windtree Therapeutics Competitors and Similar CompaniesClear all

Windtree Therapeutics's competitors and similar companies include Biogen and Alembic Pharmaceuticals.
Windtree Therapeutics
Windtree Therapeutics
Windtree Therapeutics, Inc. is a biotech company focused on developing novel KL4 surfactant therapies for respiratory diseases and other potential applications.
Biogen
Biogen
Biogen (formerly known as Biogen Idec) is a biopharmaceutical company that develops and delivers therapies for neurological and neurodegenerative diseases.
Alembic Pharmaceuticals
Alembic Pharmaceuticals
Alembic Pharmaceuticals is a company that develops, manufactures, and markets pharmaceutical products, pharmaceutical substances, and intermediates
Founding Date
Founding Date
1992
Founding Date
1978
Founding Date
2010
Type
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Warrington, US HQ
Locations
Cambridge, US HQ
Vicente López, AR
Macquarie Park, AU
Wien, AT
Machelen, BE
São Paul, BR
Toronto, CA
see more
Locations
Vadodara, IN HQ
Baska, IN
Mumbai, IN
Namthang, IN
Vadodara, IN
Vadodara, IN
Employees
Employees
3219% increase
Employees
7,605
Employees
14,858
Valuation ($)
Valuation ($)
3 m
Valuation ($)
26.7 b
Valuation ($)
N/A

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
$9.9b (FY, 2025)
Revenue (est.)
₹73.4b (FY, 2026)
Cost of goods
Cost of goods
N/A
Cost of goods
$2.4b (FY, 2025)
Cost of goods
₹19.8b (FY, 2026)
Gross profit
Gross profit
N/A
Gross profit
$7.5b (FY, 2025)
Gross profit
₹54.1b (FY, 2026)
Net income
Net income
($1.8m) (FY, 2024)
Net income
$1.3b (FY, 2025)
Net income
₹6.7b (FY, 2026)
For sources of this data, please see the company profile

View Company Profiles

Biogen
HQ
Cambridge, US
Employees
7,605

Biogen (formerly known as Biogen Idec) is a biopharmaceutical company that develops and delivers therapies for neurological and neurodegenerative diseases.

View company
Alembic Pharmaceuticals
HQ
Vadodara, IN
Employees
14,858

Alembic Pharmaceuticals is a company that develops, manufactures, and markets pharmaceutical products, pharmaceutical substances, and intermediates

View company